Carcinoma, Small Cell
Information
- Disease name
- Carcinoma, Small Cell
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04660929 | Active, not recruiting | Phase 1 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | February 2, 2021 | December 31, 2024 |
| NCT00046787 | Completed | Phase 2 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | September 2002 | February 2003 |
| NCT00126828 | Completed | Phase 1/Phase 2 | Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer | January 2003 | October 2007 |
| NCT00191750 | Completed | Phase 2 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | July 2004 | September 2006 |
| NCT00284154 | Completed | Phase 2 | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | January 2006 | November 2009 |
| NCT00294190 | Completed | Phase 2 | Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | February 2006 | July 2009 |
| NCT00298896 | Completed | Phase 2 | Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | February 2006 | June 2008 |
| NCT00305942 | Completed | Phase 2 | Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer | March 2006 | November 2009 |
| NCT00359359 | Completed | Phase 1/Phase 2 | A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer | July 2006 | August 2009 |
| NCT00412880 | Completed | Phase 2 | BI 2536 Second Line Monotherapy in SCLC | February 14, 2007 | June 30, 2008 |
| NCT00826644 | Completed | Phase 3 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | January 2009 | February 2013 |
| NCT01470248 | Completed | Phase 2 | Study of Arsenic Trioxide in Small Cell Lung Cancer | August 2011 | January 2016 |
| NCT01860898 | Completed | N/A | A Phase I Study of iPS Cell Generation From Patients With COPD | September 2009 | October 28, 2014 |
| NCT03092739 | Completed | A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens | May 3, 2017 | June 6, 2018 | |
| NCT04854590 | Completed | IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer | April 22, 2021 | August 31, 2023 | |
| NCT05500391 | Recruiting | Phase 2 | Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring | February 28, 2024 | October 2029 |
| NCT00100256 | Recruiting | Phase 1/Phase 2 | Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy | January 2004 | April 20, 2025 |
| NCT03212404 | Recruiting | Phase 1 | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | September 20, 2017 | December 2024 |
| NCT03554473 | Recruiting | Phase 1/Phase 2 | M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers | September 11, 2018 | January 15, 2025 |
| NCT05461430 | Recruiting | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | July 15, 2022 | July 2026 | |
| NCT00537511 | Terminated | Phase 1/Phase 2 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | February 1, 2008 | December 1, 2010 |
| NCT00094978 | Terminated | Phase 1 | Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum | October 25, 2004 | May 20, 2013 |
| NCT00129974 | Terminated | Phase 2 | Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer | August 2005 | October 2006 |
| NCT02034123 | Terminated | Phase 1 | Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma | February 4, 2014 | April 18, 2017 |
| NCT02608411 | Terminated | Phase 2 | TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) | February 19, 2016 | February 21, 2017 |
| NCT00324558 | Terminated | Phase 2 | Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) | June 2005 | September 2010 |
| NCT00447421 | Terminated | Phase 1/Phase 2 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | February 2007 | May 2008 |
| NCT02675088 | Unknown status | N/A | Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer | December 1, 2017 | December 2019 |
| NCT02366741 | Unknown status | N/A | Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study | January 2015 | January 2017 |
| NCT02688036 | Unknown status | Phase 3 | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC | February 2016 | May 2020 |
| NCT01900951 | Unknown status | Phase 2 | Temozolomide as Maintenance Therapy in Small Cell Lung Cancer | January 2013 | June 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018288